Co-production deals with adalimumab biosimilar manufacturers and PBMs have increased biosimilar adoption, but this ...

Wockhardt will deepen its novel antibiotics pipeline over the next five years and focus on building a biosimilar business for ...

Rising biosimilar adoption, shifting market dynamics, and escalating supply chain vulnerabilities are driving change in ...

After thousands of HHS employees had their jobs were being eliminated, healthcare leaders are concerned about the future of ...

Trump cutbacks were supposedly aimed at administrators. But scientists in food and drug-testing labs and policy experts who advance generic drug approvals were also dismissed.

The US has exempted Indian pharmaceuticals from tariffs amidst President Trump’s broad tariff imposition, recognizing their ...

Abbott's Diabetes Care business continues to benefit from the growing sales of its flagship, sensor-based continuous glucose ...

NMC guidelines urge doctors to prescribe generic drugs, but patients struggle to find them, leading to brand prescriptions.

New Delhi, Apr 3 (PTI) The Trump administration has exempted the Indian pharma sector from reciprocal tariffs, recognising the vital role played by the domestic industry in supplying affordable ...

The US has exempted Indian pharmaceuticals from reciprocal tariffs, highlighting the critical role of generic medicines. | ...

Amid growing legislative pressures and industry debates, pharmacy benefit managers (PBMs) are exploring new strategies to ...

Associate Health Minister David Seymour is welcoming Cabinet's decision to enable medicines to be approved in less than 30 days if the product has ...